Literature DB >> 23747571

Addiction as a stress surfeit disorder.

George F Koob1, Cara L Buck, Ami Cohen, Scott Edwards, Paula E Park, Joel E Schlosburg, Brooke Schmeichel, Leandro F Vendruscolo, Carrie L Wade, Timothy W Whitfield, Olivier George.   

Abstract

Drug addiction has been conceptualized as a chronically relapsing disorder of compulsive drug seeking and taking that progresses through three stages: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation. Drug addiction impacts multiple motivational mechanisms and can be conceptualized as a disorder that progresses from positive reinforcement (binge/intoxication stage) to negative reinforcement (withdrawal/negative affect stage). The construct of negative reinforcement is defined as drug taking that alleviates a negative emotional state. Our hypothesis is that the negative emotional state that drives such negative reinforcement is derived from dysregulation of key neurochemical elements involved in the brain stress systems within the frontal cortex, ventral striatum, and extended amygdala. Specific neurochemical elements in these structures include not only recruitment of the classic stress axis mediated by corticotropin-releasing factor (CRF) in the extended amygdala as previously hypothesized but also recruitment of dynorphin-κ opioid aversive systems in the ventral striatum and extended amygdala. Additionally, we hypothesized that these brain stress systems may be engaged in the frontal cortex early in the addiction process. Excessive drug taking engages activation of CRF not only in the extended amygdala, accompanied by anxiety-like states, but also in the medial prefrontal cortex, accompanied by deficits in executive function that may facilitate the transition to compulsive-like responding. Excessive activation of the nucleus accumbens via the release of mesocorticolimbic dopamine or activation of opioid receptors has long been hypothesized to subsequently activate the dynorphin-κ opioid system, which in turn can decrease dopaminergic activity in the mesocorticolimbic dopamine system. Blockade of the κ opioid system can also block anxiety-like and reward deficits associated with withdrawal from drugs of abuse and block the development of compulsive-like responding during extended access to drugs of abuse, suggesting another powerful brain stress/anti-reward system that contributes to compulsive drug seeking. Thus, brain stress response systems are hypothesized to be activated by acute excessive drug intake, to be sensitized during repeated withdrawal, to persist into protracted abstinence, and to contribute to the development and persistence of addiction. The recruitment of anti-reward systems provides a powerful neurochemical basis for the negative emotional states that are responsible for the dark side of addiction. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Abstinence or withdrawal; Compulsive; Corticotropin-releasing factor; Dynorphin; Extended amygdala; Impulsive; Opponent process; Prefrontal cortex; Reward; Sensitization

Mesh:

Substances:

Year:  2013        PMID: 23747571      PMCID: PMC3830720          DOI: 10.1016/j.neuropharm.2013.05.024

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  149 in total

1.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

2.  Regulation of cocaine reward by CREB.

Authors:  W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

3.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

4.  Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.

Authors:  Sonia Tucci; Survjit Cheeta; Pallab Seth; Sandra E File
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

5.  Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats.

Authors:  Adrie W Bruijnzeel; Elysia Small; Tim M Pasek; Hidetaka Yamada
Journal:  Behav Brain Res       Date:  2010-03-01       Impact factor: 3.332

6.  Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.

Authors:  Sunmee Wee; Zhixia Wang; William L Woolverton; Luigi Pulvirenti; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

7.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

8.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

Review 9.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

10.  Compulsive drug seeking by rats under punishment: effects of drug taking history.

Authors:  Yann Pelloux; Barry J Everitt; Anthony Dickinson
Journal:  Psychopharmacology (Berl)       Date:  2007-05-21       Impact factor: 4.530

View more
  186 in total

Review 1.  The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward?

Authors:  Patrick H Finan; Bethany Remeniuk; Kelly E Dunn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-01       Impact factor: 5.067

Review 2.  Integrated circuits and molecular components for stress and feeding: implications for eating disorders.

Authors:  J A Hardaway; N A Crowley; C M Bulik; T L Kash
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

3.  Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats.

Authors:  Brooke E Schmeichel; Estelle Barbier; Kaushik K Misra; Candice Contet; Joel E Schlosburg; Dimitri Grigoriadis; John P Williams; Camilla Karlsson; Caleb Pitcairn; Markus Heilig; George F Koob; Leandro F Vendruscolo
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 4.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 5.  Dynorphin, Dysphoria, and Dependence: the Stress of Addiction.

Authors:  Charles Chavkin; George F Koob
Journal:  Neuropsychopharmacology       Date:  2016-01       Impact factor: 7.853

6.  The etiology of DSM-5 alcohol use disorder: Evidence of shared and non-shared additive genetic effects.

Authors:  Rohan H C Palmer; Leslie A Brick; Yi-Ling Chou; Arpana Agrawal; John E McGeary; Andrew C Heath; Laura Bierut; Matthew C Keller; Eric Johnson; Sarah M Hartz; Marc A Schuckit; Valerie S Knopik
Journal:  Drug Alcohol Depend       Date:  2019-06-14       Impact factor: 4.492

7.  Evaluating a longitudinal mediation model of perceived stress, depressive symptoms, and substance use treatment outcomes.

Authors:  Corey R Roos; Brian D Kiluk; R Kathryn McHugh; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2020-04-16

Review 8.  A review of treatment options for co-occurring methamphetamine use disorders and depression.

Authors:  Tracy L Hellem; Kelly J Lundberg; Perry F Renshaw
Journal:  J Addict Nurs       Date:  2015 Jan-Mar       Impact factor: 1.476

9.  Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers.

Authors:  Steven J Nieto; Erica N Grodin; ReJoyce Green; Lara A Ray
Journal:  Drug Alcohol Depend       Date:  2021-02-13       Impact factor: 4.492

10.  κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.

Authors:  Timothy W Whitfield; Joel E Schlosburg; Sunmee Wee; Adam Gould; Olivier George; Yanabel Grant; Eva R Zamora-Martinez; Scott Edwards; Elena Crawford; Leandro F Vendruscolo; George F Koob
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.